Wang Tao

27PUBLICATIONS
131CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsGene expression (incl. microarray and other genome-wide approaches)Gene and molecular therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (27)

|Aug 10, 2026
Targeting oncogenic FLT3 uncovers a ferroptosis vulnerability through selenocysteine recoding in acute myeloid leukaemia.

|Jan 02, 2026
Autologous multiantigen-targeted T cell therapy for pancreatic cancer: a phase 1/2 trial.

Benjamin L Musher, Spyridoula Vasileiou, Brandon G Smaglo

|Feb 17, 2025
Long-term outcomes of GD2-directed CAR-T cell therapy in patients with neuroblastoma.

Che-Hsing Li, Sandhya Sharma, Andras A Heczey

|Nov 28, 2024
Interleukin-15-armoured GPC3 CAR T cells for patients with solid cancers.

David Steffin, Nisha Ghatwai, Antonino Montalbano

|Sep 11, 2024
Comparing the Diagnostic Yield of Germline Exome Versus Panel Sequencing in the Diverse Population of the Texas KidsCanSeq Pediatric Cancer Study.

Lauren R Desrosiers-Battu, Tao Wang, Jacquelyn Reuther

|May 21, 2024
Phase I Trial of GD2.CART Cells Augmented With Constitutive Interleukin-7 Receptor for Treatment of High-Grade Pediatric CNS Tumors.

Frank Y Lin, Austin Stuckert, Candise Tat

Pageof 5

Frequent Collaborators

12 joint publications

Helen Heslop

9 joint publications

Susan G Hilsenbeck

7 joint publications

Andras Heczey

6 joint publications

Rachel Schiff